Fukushima will get custom-made robot to look for leaks. voiceofrussia.com

In defiance of fierce public objection to the government policies of restarting off-line nuclear reactors and promoting the Trans-Pacific Partnership free trade framework, Japan’s prime minister devoted his time to expanding the markets for Japanese nuclear- and military-related companies during his 10-day visit to six European nations, including Germany, Britain, and France. japan-press.co.jp

Virginia’s North Anna nuclear plant briefly lost one off-site power line Thursday, causing two emergency diesel generators to start automatically. nuclearstreet.com

In order to alleviate energy dependence on Moscow, the coup-imposed government in Kiev has resurrected a contract with a US company to supply fuel to Ukraine’s nuclear power plants.  rt.com

TEPCO said May 14 that groundwater collected before it reaches the Fukushima Unit 1 nuclear reactor  will be released into the sea next week. ajw.asahi.com

The source of the radioactive leak at the earthquake-stricken Fukushima Daiichi nuclear power plant was finally identified by the facility’s operator TEPCO to be in the primary containment vessel of the Unit 3 reactor. rt.com

The US Nuclear Regulatory Commission (NRC) has drawn up a list of 21 nuclear power stations in the central and eastern US that must carry out in-depth analysis of updated earthquake risks “as a matter of priority.” nucnet.com

A safety evaluation group carrying out a re-inspection of the Lungmen-1 nuclear reactor unit in Taiwan will complete its work and report to the government in mid-2014. nucnet.com

          I have blogged extensively about the health effects of ionizing radiation. Some organisms have the ability to resist the effects of radiation, primarily through error correcting protein creation. A recent report in the journal Science Translational Medicine details research results of a new method of dealing with radiation damage from the ingestion of radioactive particles which could otherwise be fatal.

          A major terrorist threat is the possibility of a “dirty bomb.” This type of bomb does not detonate radioactive isotopes to create a nuclear explosion. Instead, a conventional explosive is surrounded by radioactive materials. When the bomb detonates, radioactive particles are spread over a wide area. The population in the area of the detonation would be vulnerable to inhaling or ingesting these radioactive particles. Another possibility would be to grind up a radioactive material such as plutonium, mix it with the gasoline in the tank of a car and drive the car around a heavily populated area. A tiny amount of plutonium could contaminate a large area and threaten anyone living in that area. The U.S. Institute of Health has been funding research on drugs that could be administered to people living in an area hit by a dirty bomb to help combat the health threat of the dispersed radioactive particles.

      A drug named dimethyloxallyl glycine (DMOG) has been tested in mice. This drug neutralizes enzymes which normally function to reduce the level of a particular protein named hypoxia-inducible factor 2. This protein protects the cells that line the digestive tract from radiation damage. With the reduction of the enzymes, higher levels of this protein result in greater protection. In tests, mice given the drug were able to survive a dose of radiation that killed unprotected mice through water loss and diarrhea. Administering “small-molecule dimethyloxallyl glycine (DMOG) increases hypoxia-inducible factor (HIF) expression (responds to reduced oxygen in the cells) , improves epithelial integrity (strengthens the cells lining the gut) , reduces apoptosis (decreases cell death), and increases intestinal angiogenesis (supports formation of new blood vessels) , all of which are essential for radioprotection.” This drug could be distributed to victims of a dirty bomb attack to save lives.

      In addition to the possibility use of this drug to treat people exposed to radioactive materials from a dirty bomb, there has also been discussion of the possibility of the use of this drug in radiation therapy. Current radiation therapy for cancer focuses the radiation narrowly on a tumor. With the use of DMOG, it may be possible to subject the whole body of a patient to radiation treatment to deal with a metastasizing cancer which is spreading cancer cells to other parts of the body.

     In addition to treating dirty bomb victims and protecting patients receiving radiation therapy, DMOG will be useful in dealing with exposure to radioactive particles loose in the environment from accidents at nuclear power plants and the improper treatment nuclear waste. These will only increase as time goes by and the use of such drugs may eventually be widespread.

Structure of dimethyloxallyl glycine:

dimethyloxallyl glycine.png

A new study reveals deaths and mutations ”increased sharply” from exposure to Fukushima contamination, “especially at low doses.” enenews.com

Animals dead from “mystery disease” on the Pacific coast of Alaska are being tested for Fukushima radiation. enenews.com

Wildfires had burned nearly 1,000 acres in San Diego County by Thursday afternoon but did not pose a threat to the San Onofre Nuclear plant shuttered last year. nuclearstreet.com

Workers at the Indian Point nuclear power plant mistakenly tried twice to place a second bundle of used nuclear fuel into a spot already holding one during maintenance work in March. lohud.com

France is planning to introduce commercial fast neutron nuclear reactors (FNRs) in 2040 and to phase out its operational Generation II light water reactors (LWRs) by 2050, a conference has heard. nucnet.org

            I have blogged a lot about the decline of the U.S. nuclear industry.  The Fukushima disaster, rising costs, aging reactors, cheap natural gas and other factors have been eroding support and investment for new reactors. Recently a report, Renaissance in Reverse: Competition Pushes Aging U.S. Nuclear Reactors to the Brink of Economic Abandonment, came out and offered some details about the future of the nuclear industry in the United States. A few years ago, there were one hundred and four nuclear power reactors in the United States. Four of those reactors have been designated for permanent closure. Some of the closures were related to technical issues but one happened because the operators could not make a profit and could not find a buyer. Another reactor was shut down because it had become too expensive to fix. In addition there have been cancellations of five projects to increase the output of five reactors because of rising costs.

           The report utilizes eleven risk factors to project the future of individual reactors.  including cost of electricity greater than the current wholesale market, commissioned before 1974, smaller than  seven hundred megawatts, major systems broken, suffering multiple outages, single reactor at power plant, suffering long term outages, multiple safety issues and needing retrofit because of new standards triggered by Fukushima disaster. These risk factors were extracted from Wall Street analyses that were intended for investors who might be considering an investment in nuclear power.

           When the hundred operating reactors are tested against these risk factors, over three dozen of the operating U.S. power reactors have four or more of the risk factors. The purpose of this report is to indicate which of the existing reactors are most likely going to be retired soon. A review of the report reveals that many of the problems that suggest retirement are not new but have been around since the beginning of nuclear power generation in the U.S. “The problems are endemic to the technology and the sector.” In addition, the rising cost of keep the aging U.S reactor fleet working and the presence of low cost alternative energy sources including cheap natural gas and renewables will likely continue for the next several decades.

          When I criticize nuclear power, proponents offer a number of defenses, some of them sound and some questionable. I always patiently explain that nuclear power is an extremely complex subject with economic issues, health issues, political issues, social issues, environmental issues, technical issues and other considerations. While it might be defendable on some specific challenges, when many factors are taken into account, it becomes obvious that nuclear power is just not a viable choice for the future of U.S. energy generation. The analysis in the report goes a long way toward validating my contention. As the Wall Street Journal analysis found, investing in the replacement of old U.S. power reactors with new nuclear reactors is just not a good bet.

Reactor map for US.png

Work has begun towards implementing a way to remove the melted fuel at Fukushima Daiichi. fukuleaks.org

A new law has been enacted by the Japanese Diet to allow the current entity dealing with compensation for Fukushima victims to now also manage much of the decommissioning of Fukushima Daiichi.  fukuleaks.org

In the United Kingdom, Sellafield Ltd is pressing cutting-edge 3D printing technology into service to help meet the challenges of decommissioning one of the world’s oldest and most complex nuclear sites. world-nuclear-news.org

The many tens of billions of dollars needed to scale up production of small modular reactors (SMRs) in the U.S. would effectively choke off funds needed to shift the nation to an electricity generation system more heavily reliant on renewable energy (including wind and solar) and enhanced energy efficiency, yournuclearnews.com